|
PT90657B
(pt)
|
1988-05-27 |
1995-03-01 |
Ortho Pharma Corp |
Processo para a preparacao de peptidos que bloqueiam a ligacao de hiv-1 a proteina cd4 receptora
|
|
JPH0768273B2
(ja)
*
|
1988-12-02 |
1995-07-26 |
カルピス食品工業株式会社 |
抗ｈｉｖペプチド
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
AU5656890A
(en)
|
1989-05-02 |
1990-11-29 |
Genelabs Incorporated |
Chemically modified cd4 peptide fragments having anti-retroviral properties
|
|
GB8912497D0
(en)
|
1989-05-31 |
1989-07-19 |
Cobbold Stephen P |
Monoclonal antibodies
|
|
US5690933A
(en)
|
1989-05-31 |
1997-11-25 |
Glaxo Wellcome Inc. |
Monoclonal antibodies for inducing tolerance
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
US20020099179A1
(en)
|
1989-12-21 |
2002-07-25 |
Linda K. Jolliffe |
Cdr-grafted antibodies
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
HUT60768A
(en)
|
1990-03-16 |
1992-10-28 |
Sandoz Ag |
Process for producing cd25 fixing molecules
|
|
US7084260B1
(en)
|
1996-10-10 |
2006-08-01 |
Genpharm International, Inc. |
High affinity human antibodies and human antibodies against human antigens
|
|
DE69126301T2
(de)
|
1990-11-27 |
1998-01-02 |
Biogen, Inc., Cambridge, Mass. |
Hiv-induzierte synzytien blockierender anti-cd-4-antikörper
|
|
US7192584B2
(en)
|
1991-03-18 |
2007-03-20 |
Centocor, Inc. |
Methods of treating psoriasis with anti-TNF antibodies
|
|
US6136310A
(en)
|
1991-07-25 |
2000-10-24 |
Idec Pharmaceuticals Corporation |
Recombinant anti-CD4 antibodies for human therapy
|
|
JPH05244982A
(ja)
|
1991-12-06 |
1993-09-24 |
Sumitomo Chem Co Ltd |
擬人化ｂ−ｂ１０
|
|
US5777085A
(en)
|
1991-12-20 |
1998-07-07 |
Protein Design Labs, Inc. |
Humanized antibodies reactive with GPIIB/IIIA
|
|
IL101769A
(en)
|
1992-05-03 |
2007-02-11 |
Yeda Res & Dev |
Modulation of TNF receptor action
|
|
US6270766B1
(en)
|
1992-10-08 |
2001-08-07 |
The Kennedy Institute Of Rheumatology |
Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
|
|
AU5152293A
(en)
|
1992-10-08 |
1994-05-09 |
Kennedy Institute Of Rheumatology, The |
Treatment of autoimmune and inflammatory disorders
|
|
ATE204299T1
(de)
|
1993-03-05 |
2001-09-15 |
Bayer Ag |
Humane monoklonale anti-tnf alpha antikörper
|
|
EP0631783A1
(en)
|
1993-06-03 |
1995-01-04 |
Mitsubishi Chemical Corporation |
Antiviral combinations of 2',3'-di-deoxyribonucleosides with 6-benzyl-1-ethoxymethyl-5-substituted uracil derivatives
|
|
JPH09510952A
(ja)
|
1993-10-06 |
1997-11-04 |
ザ ケネディー インスティチュート オブ リューマトロジー |
自己免疫疾患および炎症性疾患の治療
|
|
US20020068057A1
(en)
|
1994-03-10 |
2002-06-06 |
Marc Feldmann |
Treatment of autoimmune and inflammatory disorders
|
|
EP0840618B1
(en)
|
1995-05-18 |
2003-04-23 |
Ortho-McNeil Pharmaceutical, Inc. |
Induction of immunological tolerance by the use of non-depleting anti-cd4 antibodies
|
|
ATE239041T1
(de)
|
1996-02-09 |
2003-05-15 |
Basf Ag |
Humane antikörper welche an humanen tnfalpha binden
|
|
US20010056066A1
(en)
|
1996-07-26 |
2001-12-27 |
Smithkline Beecham Corporation |
Method of treating immune cell mediated systemic diseases
|
|
EP0946195A1
(en)
|
1996-10-01 |
1999-10-06 |
Celltech Therapeutics Limited |
Pharmaceutical products containing protein-tyrosine kinase inhibitors and anti-cd4 antibodies
|
|
US6037454A
(en)
|
1996-11-27 |
2000-03-14 |
Genentech, Inc. |
Humanized anti-CD11a antibodies
|
|
DE19722888A1
(de)
|
1997-05-28 |
1998-12-03 |
Thomas Prof Dr Huenig |
Human-CD28 spezifische monoklonale Antikörper zur antigenunspezifischen Aktivierung von T-Lymphozyten
|
|
WO2000058362A1
(en)
|
1999-03-26 |
2000-10-05 |
Human Genome Sciences, Inc. |
Neutrokine-alpha binding proteins and methods based thereon
|
|
DE60042785D1
(de)
|
1999-06-09 |
2009-10-01 |
Immunomedics Inc |
Immuntherapie von autoimmunerkrankungen durch die verwendung von b-zell spezifischen antikörpern
|
|
WO2001016182A2
(en)
*
|
1999-08-27 |
2001-03-08 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
POLYPEPTIDES THAT BIND HIV gp120 AND RELATED NUCLEIC ACIDS, ANTIBODIES, COMPOSITIONS, AND METHODS OF USE
|
|
US7304127B2
(en)
|
1999-08-27 |
2007-12-04 |
United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Polypeptides that bind HIV gp120 and related nucleic acids, antibodies, compositions, and methods of use
|
|
WO2001093908A1
(en)
|
2000-06-02 |
2001-12-13 |
Regents Of The University Of Minnesota |
Immunotherapeutic method to prevent islet cell rejection
|
|
WO2002022212A2
(en)
|
2000-09-18 |
2002-03-21 |
Idec Pharmaceuticals Corporation |
Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination
|
|
DE10050935A1
(de)
|
2000-10-11 |
2002-05-02 |
Tegenero Gmbh |
Verwendung CD28 spezifischer monoklonaler Antikörper zur Stimulation von Blutzellen, welche kein CD28 tragen
|
|
CA2434972C
(en)
|
2001-01-16 |
2010-06-08 |
Vascular Therapies, Llc |
Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
|
|
NZ528250A
(en)
|
2001-03-07 |
2006-09-29 |
Childrens Medical Center |
Method to screen peptide display libraries using minicell display
|
|
EP1241249A1
(en)
|
2001-03-12 |
2002-09-18 |
Gerold Schuler |
CD4+CD25+regulatory T cells from human blood
|
|
CN1247258C
(zh)
|
2001-04-24 |
2006-03-29 |
默克专利有限公司 |
使用抗血管生成剂和TNFα的联合疗法
|
|
GB2376466A
(en)
|
2001-06-14 |
2002-12-18 |
Mark Frewin |
TRX1 antibody
|
|
DE60238533D1
(de)
|
2001-06-14 |
2011-01-20 |
Cambridge Entpr Ltd |
Nicht-depletierender Antikörper TRX-1 gegen CD4 und dessen Verwendungen
|
|
US7541443B2
(en)
|
2001-06-14 |
2009-06-02 |
Tolerrx, Inc. |
Anti-CD4 antibodies
|
|
ES2392287T3
(es)
|
2001-12-04 |
2012-12-07 |
Theramab Llc |
Péptido o proteína que contiene un bucle C'-D de la familia de receptores de la CD28
|
|
DE10212108A1
(de)
|
2002-03-13 |
2003-10-02 |
Tegenero Ag |
Verwendung einer an CD28 bindenden Wirksubstanz zur Herstellung einer pharmazeutischen Zusammensetzung
|
|
DE10230223A1
(de)
|
2002-07-04 |
2004-01-22 |
Tegenero Ag |
Mikropartikel mit CD28-spezifischen monoklonalen Antikörpern
|
|
AU2003291625B2
(en)
|
2002-09-16 |
2009-10-08 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US7388079B2
(en)
*
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
|
US7501494B2
(en)
|
2003-01-15 |
2009-03-10 |
United Biomedical, Inc. |
Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection
|
|
EP1460088A1
(en)
*
|
2003-03-21 |
2004-09-22 |
Biotest AG |
Humanized anti-CD4 antibody with immunosuppressive properties
|
|
ME00426B
(me)
|
2003-04-09 |
2011-10-10 |
Genentech Inc |
Liječenje autoimunih bolesti kod pacijenata sa neadekvatnim odgovorom na tnf-alfa inhibitor
|
|
GB0314461D0
(en)
|
2003-06-20 |
2003-07-23 |
Isis Innovation |
Suppression of transplant rejection
|
|
US7691970B2
(en)
|
2003-08-25 |
2010-04-06 |
Pieris Ag |
Muteins of a bilin-binding protein with affinity for a given target
|
|
EP1600164A3
(de)
|
2003-09-22 |
2006-05-17 |
TeGenero AG |
Verwendung einer an CD28 bindenden Wirksubstanz zur Herstellung einer Pharmazeutischen Zusammensetzung mit dosisabhängiger Wirkung
|
|
DE10352900A1
(de)
|
2003-11-11 |
2005-06-16 |
Tegenero Ag |
Verwendung einer an CD28 bindenden Wirksubstanz zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von B-CLL
|
|
RU2007102055A
(ru)
|
2004-06-22 |
2008-07-27 |
Толерркс, Инк. (Us) |
Оптимизированное введение доз анти-cd4-антител для индукции толерантности у приматов
|
|
RU2007104022A
(ru)
|
2004-07-02 |
2008-08-10 |
Дженентек, Инк. (Us) |
Композиции для лечения неходжкинской лимфомы и способы их применения
|
|
US20070270431A1
(en)
|
2004-09-29 |
2007-11-22 |
Kowa Co., Ltd. |
Preventive and/or Therapeutic Medicine for Rheumatoid Arthritis
|
|
WO2006050949A2
(de)
|
2004-11-11 |
2006-05-18 |
Tegenero Ag |
Superagonistische anti-cd28 antikörper
|
|
US8119589B2
(en)
|
2004-11-12 |
2012-02-21 |
University Of North Carolina At Charlotte |
Modulation of CD4+ T cell responses by a tick saliva protein, Salp15 and polypeptides derived therefrom
|
|
DE102004063494A1
(de)
|
2004-12-23 |
2006-07-13 |
Tegenero Ag |
Antikörper
|
|
JP4730733B2
(ja)
|
2005-05-02 |
2011-07-20 |
国立大学法人京都大学 |
４型葉酸受容体の発現を指標とした制御性ｔ細胞の検出方法、及び免疫賦活剤
|
|
US8663634B2
(en)
|
2005-07-11 |
2014-03-04 |
Macrogenics, Inc. |
Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
|
|
NZ594784A
(en)
|
2005-08-18 |
2013-06-28 |
Genmab As |
Therapy with CD4 binding peptides and radiation
|
|
AU2006290433B2
(en)
|
2005-08-26 |
2012-06-07 |
Roche Glycart Ag |
Modified antigen binding molecules with altered cell signaling activity
|
|
US8101365B2
(en)
*
|
2006-01-05 |
2012-01-24 |
Genentech, Inc. |
Anti-EphB4 antibodies and methods using same
|
|
US20070218062A1
(en)
|
2006-03-16 |
2007-09-20 |
Genentech, Inc. |
Methods of treating lupus using CD4 antibodies
|
|
JP2009529915A
(ja)
*
|
2006-03-20 |
2009-08-27 |
ゾーマ テクノロジー リミテッド |
ガストリン物質に対して特異的なヒト抗体および方法
|
|
WO2007117602A2
(en)
|
2006-04-07 |
2007-10-18 |
Biogen Idec Ma Inc. |
Isolation and use of human regulatory t cells
|
|
SMP200800064B
(it)
|
2006-04-21 |
2009-11-06 |
Novartis Ag |
Composizioni farmaceutiche di anticorpi anti-cd40 antagonista
|
|
WO2007135684A2
(en)
*
|
2006-05-22 |
2007-11-29 |
Hadasit Medical Research Services & Development Limited |
Method of treatment of anti-cd4 autoimmunity
|
|
US8557533B2
(en)
|
2007-02-01 |
2013-10-15 |
Helmut Jonuleit |
Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4
|
|
EP3067368A1
(en)
|
2007-04-27 |
2016-09-14 |
Genentech, Inc. |
Potent, stable and non-immunosuppressive anti-cd4 antibodies
|
|
RU2539110C2
(ru)
|
2008-03-13 |
2015-01-10 |
Биотест Аг |
Способ лечения аутоиммунного заболевания (варианты)
|
|
MX2010010027A
(es)
|
2008-03-13 |
2011-05-02 |
Biotest Ag |
Agente para tratar enfermedad.
|
|
EP2262838B1
(en)
|
2008-03-13 |
2016-04-13 |
Biotest AG |
Agent for treating disease
|
|
EP2101173A1
(en)
|
2008-03-14 |
2009-09-16 |
Vivalis |
In vitro method to determine whether a drug candidate active against a target protein is active against a variant of said protein
|
|
WO2010022341A1
(en)
|
2008-08-21 |
2010-02-25 |
The United State Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of enriching and using regulatory t cells
|
|
ES2335381B1
(es)
|
2008-09-24 |
2011-02-28 |
Fundacio Institut De Recerca De L'hospital Universitari Vall D'hebron |
Metodo in vitro y kit para el pronostico o prediccion de la respuestapor parte de pacientes con artritis reumatoide al tratamiento con agentes bloqueantes del factor tnfalfa.
|
|
RU2531548C2
(ru)
*
|
2008-09-29 |
2014-10-20 |
Биотест Аг |
Композиция для лечения заболевания
|
|
ES2351456B1
(es)
|
2009-06-24 |
2011-11-28 |
Fundacio Institut De Recerca De L'hospital Universitari Vall D'hebron |
Metodo in vitro para el pronostico o prediccion de la respuesta por parte de pacientes con artritis reumatoide al tratamiento con agentes que reconocen el receptor de membrana cd20 de los linfocitos b
|
|
JP5399219B2
(ja)
|
2009-11-24 |
2014-01-29 |
株式会社ケイティーバイオ |
関節リウマチに対するヒト型抗ＴＮＦα抗体薬の薬効予測方法、及び薬効予測装置
|
|
WO2011158798A1
(ja)
|
2010-06-14 |
2011-12-22 |
国立大学法人山口大学 |
乾癬治療効果の経過観察及び早期の予測方法並びにそれらに使用するキット
|